AirSculpt Technologies, Inc.

NASDAQ:AIRS

Medical - Care Facilities

Healthcare
$0.72 +4.45%

+$0.21 today

Market cap
$53.08M
Beta
2.34
P/E (TTM)
-31.1
EPS (TTM)
-$0.16
52W Low $1.51High $12.00

Volume 0.49M

Average 1.46M

AIRS Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

AirSculpt Technologies, Inc.NASDAQ: AIRS

Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026

Cost of revenue growth accelerates

Q1 FY2026 cost of revenue of $18.61M rose 31.5% year over year, ahead of the -4.1% change in trailing-twelve-month cost of revenue. Sequentially, it rose 36.1% from the prior quarter. Over 3 fiscal years it compounded at +1.9% a year.

Context

  • Cost of revenue amounted to 40.6% of revenue in FY2025, up 1.1 pp from a year earlier.
  • Cost of revenue increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +31.5% holds above the trailing-twelve-month pace of -4.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$18.61M+36.1% QoQ
Last fiscal yearDec 2025
$61.69M-13.6% YoY
LTMMar 2026
$59.85M-4.1% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+31.5%——
1 year-13.6%——
3-year CAGR+1.9%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
61.69M USD
Year-over-year change
-13.6%
4-year CAGR
+8.5%

Cost of Revenue vs competitors

How AIRS compares with its peers on the latest reported figures

  • AIRS's LTM Mar 2026 cost of revenue of $59.85M is the 6th highest of the 11 companies compared; the peer median is $71.39M.
  • Its year-over-year change of -4.1% is the 9th highest of 10, against a peer median of +9.8%.
  • Cost of revenue amounts to 39.4% of revenue for AIRS, versus a peer median of 44.9%.
AIRS Competitors Peer median
Cost of Revenue for AIRS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CYHCommunity Health Systems, Inc.LTM Mar 2026$9.96B +35.0%+16.0%46.3%
AMNAMN Healthcare Services, Inc.LTM Mar 2026$2.47B +21.6%-17.8%72.4%
INNVInnovAge Holding Corp.LTM Mar 2026$749.65M +9.8%-21.8%79.3%
OFIXOrthofix Medical Inc.LTM Mar 2026$255.74M -3.2%+29.9%31.0%
PACBPacific Biosciences of California, Inc.LTM Mar 2026$100.69M -21.2%+11.3%62.9%
AIRSAirSculpt Technologies, Inc.LTM Mar 2026$59.85M -4.1%+1.9%39.4%
SIBNSI-BONE, Inc.LTM Mar 2026$42.1M +14.9%+37.7%20.4%
AQSTAquestive Therapeutics, Inc.LTM Mar 2026$18.37M +7.2%-4.0%36.5%
DRIODarioHealth Corp.LTM Mar 2026$9.21M -2.6%-18.6%43.5%
MLTXMoonLake ImmunotherapeuticsLTM Mar 2026$2.34M +7090.5%——
CMPSCOMPASS Pathways plcLTM Mar 2026$0 ———
Peer median (excluding AIRS) $71.39M+9.8%+3.7%44.9%

Competitors are the stored peer set for AIRS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue133.32M168.79M195.92M180.35M151.82M
Cost of Revenue44.54M58.28M74.01M71.38M61.69M
Gross Profit88.78M110.51M121.91M108.97M90.13M
Gross Margin66.6%65.5%62.2%60.4%59.4%
Research & Development00000
Selling, General & Admin65.73M105.92M108.28M105.58M82.18M
Operating Expenses73.01M115.06M112.42M110.78M94.96M
Depreciation & Amortization6.6M8.06M10.25M11.89M12.78M
EBITDA22.37M4.6M19.74M10.07M1.22M
EBITDA Margin16.8%2.7%10.1%5.6%0.8%
Operating Income15.77M(4.55M)9.48M(1.82M)(4.83M)
Operating Margin11.8%-2.7%4.8%-1.0%-3.2%
Interest Income00000
Interest Expense4.89M6.75M6.49M6.25M6.08M
Other Income / Expenses(4.89M)(6.75M)(6.49M)(6.25M)(12.81M)
Income Before Tax10.88M(11.3M)3M(8.06M)(17.64M)
Pre-Tax Margin8.2%-6.7%1.5%-4.5%-11.6%
Income Tax Expense329K3.38M7.48M188K(5.97M)
Net Income10.55M(14.68M)(4.48M)(8.25M)(11.67M)
Net Margin7.9%-8.7%-2.3%-4.6%-7.7%
EPS (Basic)(0.01)(0.26)(0.08)(0.14)(0.19)
EPS (Diluted)(0.01)(0.26)(0.08)(0.14)(0.19)
Weighted Avg Shares55.64M55.68M56.78M57.69M60.45M
Weighted Avg Shares (Diluted)55.64M55.68M56.78M57.69M60.45M

AirSculpt Technologies, Inc.

NASDAQ:AIRS

Intrinsic Alpha fair value

Locked

Current Price

$0.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.